Federal Register Notice: FDA is seeking public comment on the information collection requirements relating to the reporting of biological product deviations in manufacturing and human cells, tissues, and cellular and tissue-based product (HCT/P) deviations, and Forms FDA 3486 and 3486A. Comments should be submitted by 8/8. To view this notice, click here.
